More intriguingly, Kaplan–Meier survival analysis cure showed that increased ZKSCAN3 in HCC patients had a shorter overall survival (OS) and disease-free survival (DFS) in HCC patients (P = 0.0032, 0.0049, respectively, Fig. 1e). This evidence concerns the gene ZKSCAN3 and hepatocellular carcinoma.